MedPath
Found 27 clinical trials|View Analysis
Sort by:

Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients With Recurrent Breast Cancer: the REPEAT Trial

Phase 2
Recruiting
Conditions
Recurrent Breast Carcinoma
Ipsilateral Recurrence
First Posted Date
2024-10-15
Last Posted Date
2024-12-11
Lead Sponsor
Amsterdam UMC, location VUmc
Target Recruit Count
25
Registration Number
NCT06640881
Locations
๐Ÿ‡ณ๐Ÿ‡ฑ

Amsterdam UMC / VU Medical Centre, Amsterdam, Netherlands

Reirradiation Dose Escalation in Thoracic Cancers

Phase 1
Not yet recruiting
Conditions
Thoracic Cancer
Lung Cancer
Esophageal Cancer
Interventions
Radiation: stereotactic body radiation therapy (SBRT)
First Posted Date
2024-08-16
Last Posted Date
2024-08-16
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
48
Registration Number
NCT06558175

Ablative Stereotactic MR-Guided Adaptive Reirradiation

Not Applicable
Recruiting
Conditions
Abdominal Cancer
Pelvic Cancer
Interventions
Radiation: Reirradiation
First Posted Date
2024-05-03
Last Posted Date
2024-12-10
Lead Sponsor
Baptist Health South Florida
Target Recruit Count
10
Registration Number
NCT06397573
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Miami Cancer Institute at Baptist Health South Florida, Miami, Florida, United States

Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study

Phase 3
Recruiting
Conditions
First Progression of Glioblastoma
Interventions
Drug: Lomustine
Radiation: Reirradiation
First Posted Date
2023-06-15
Last Posted Date
2025-01-03
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
411
Registration Number
NCT05904119
Locations
๐Ÿ‡ฉ๐Ÿ‡ฐ

Aarhus University Hospitals - Region Midtjylland - Aarhus University Hospital-Skejby, Aarhus, Denmark

๐Ÿ‡ฉ๐Ÿ‡ช

Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern, Munich, Germany

๐Ÿ‡ฆ๐Ÿ‡น

A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck, Austria

and more 26 locations

Reirradiation and Niraparib in Patients With Recurrent Glioblastoma

Phase 1
Withdrawn
Conditions
Recurrent Glioblastoma
Interventions
Drug: Niraparib
Radiation: Re-irradiation (re-RT)
First Posted Date
2022-12-27
Last Posted Date
2024-03-26
Lead Sponsor
University College, London
Registration Number
NCT05666349

Prostate Reirradiation Toxicity Outcomes Feasibility Study

Not Applicable
Not yet recruiting
Conditions
Prostate Cancer
Radiotherapy Side Effect
Interventions
Radiation: Brachytherapy
Radiation: Sterotactic Body Radiotherapy
First Posted Date
2022-11-14
Last Posted Date
2022-11-15
Lead Sponsor
University of Leeds
Target Recruit Count
60
Registration Number
NCT05614700

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

Recruiting
Conditions
Stereotactic Body Radiation Therapy
Irradiation; Reaction
Recurrent Cancer
Thoracic Tumor
First Posted Date
2022-01-12
Last Posted Date
2023-12-27
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
40
Registration Number
NCT05189054
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Peking University Third Hospital, Beijing, Beijing, China

Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse

Phase 2
Not yet recruiting
Conditions
Recurrent Cancer
Previous Radiation
Interventions
Radiation: Radiation by protontherapy associated to nanoparticles injection
First Posted Date
2021-03-05
Last Posted Date
2023-07-27
Lead Sponsor
Centre Francois Baclesse
Target Recruit Count
46
Registration Number
NCT04784221

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

Phase 1
Recruiting
Conditions
Prostate Cancer
Interventions
Drug: Metformin
Radiation: Stereotactic Body Radiation Therapy (SBRT) 30 Gray (Gy)
Radiation: Stereotactic Body Radiation Therapy (SBRT) 36 Gy
Radiation: Stereotactic Body Radiation Therapy (SBRT) 25 Gy
First Posted Date
2020-09-03
Last Posted Date
2024-03-13
Lead Sponsor
Institut Cancerologie de l'Ouest
Target Recruit Count
44
Registration Number
NCT04536805
Locations
๐Ÿ‡ซ๐Ÿ‡ท

Institut de Cancerologie de L'Ouest, Saint Herblain, France

๐Ÿ‡ซ๐Ÿ‡ท

Centre OSCAR LAMBRET, Lille, France

๐Ÿ‡ซ๐Ÿ‡ท

Clinique Victor Hugo, Le Mans, France

and more 8 locations

SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions

Not Applicable
Recruiting
Conditions
Non Small Cell Lung Cancer
Lung Metastases
Interventions
Radiation: SBRT dose escalation
First Posted Date
2020-07-02
Last Posted Date
2022-09-15
Lead Sponsor
Istituto Clinico Humanitas
Target Recruit Count
15
Registration Number
NCT04455438
Locations
๐Ÿ‡ฎ๐Ÿ‡น

Humanitas Research Hospital, Rozzano, Milano, Italy

ยฉ Copyright 2025. All Rights Reserved by MedPath